Engineering CAR T Cells to Resist Tumor Immune Suppression - Quiz - MDSpire

Engineering CAR T Cells to Resist Tumor Immune Suppression

CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models

  • March 9, 2026

  • 2 min

Share

Original Source(s)

Engineering CAR T Cells to Resist Tumor Immune Suppression

  • March 9, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review